Glaucoma is a neurodegenerative disorder characterized by mitochondrial dysfunction and an increase in oxidative damage leading to death of retinal ganglion cells (RGCs). The oxidative status of RGCs is regulated intrinsically, as well as extrinsically by retinal glia. The mitochondrial uncoupling protein 2 (UCP2) relieves oxidative and neuronal damage in a variety of neurodegenerative disease models. We hypothesized that deletion of Ucp2 in either RGCs or retinal glia would increase retinal damage and retinal ganglion cell death in a mouse model of glaucoma. Paradoxically, we found the reverse, as deletion of mitochondrial UCP2 decreased oxidative protein modification and prevented retinal ganglion cell death in male and female mice. We resolved this paradox by finding that Ucp2 deletion also increased levels of mitophagy in cell culture and markers of mitophagy in retinal tissue. Our data suggest that Ucp2 deletion facilitates increased mitochondrial function by improving quality control. An increase in mitochondrial function explains the resistance of Ucp2-deleted retinas to glaucoma and may provide a therapeutic avenue for other chronic neurodegenerative conditions.
Introduction
Glaucoma is a group of disorders marked by progressive degeneration and death of retinal ganglion cells (RGCs) that leads to irreversible visual decline. Globally, glaucoma is the most frequent cause of irreversible blindness (Resnikoff and Keys, 2012) . Primary open-angle glaucoma (POAG) is the most common form of the disease, and risk for POAG increases with age and elevated intra-ocular pressure (IOP) (Boland and Quigley, 2007; Tham et al., 2014) . However, other signs such as a change in retinal morphology or loss of visual function are sufficient for a glaucoma diagnosis without an elevated IOP (Quigley, 2011) .
Although glaucoma is often defined by the loss of RGCs, its pathophysiology is multifactorial and involves changes to multiple cell types within the inner retina, including müller glia and astrocytes (Varela and Hernandez, 1997; Carter-Dawson et al., 1998; Kawasaki et al., 2000; Woldemussie et al., 2004) . During glaucoma, the mitochondria of these cell types become dysfunctional (Lee et al., 2011; Ju et al., 2015) . Mitochondrial dysfunction can result in a bioenergetic deficit or increased levels of damaging reactive oxygen species (ROS) in the eye (Tanihara et al., 1997; Varela and Hernandez, 1997; Ferreira et al., 2010) . The restoration of mitochondrial homeostasis and anti-oxidative support to both neurons and glia of the retina and optic nerve has become a major focus in research to prevent glaucomatous neurodegeneration (Kong et al., 2009; Lee et al., 2011; Garcia-Medina et al., 2014; Shen et al., 2015; Kimura et al., 2017) .
Mitochondrial hydrogen peroxide production is highly dependent on mitochondrial pH and membrane potential (Ψ m ), and small decreases in Ψ m or pH cause significant decreases in the production of reactive oxygen species (ROS) such as H 2 O 2 (Korshunov et al., 1997; Miwa et al., 2003) . The activity of exogenous agents that decrease Ψ m cannot be easily regulated within cells and their use would risk a complete collapse of Ψ m and thus ATP production. Alternatively, it is the prototypical function of endogenous uncoupling proteins to uncouple the electron transport chain from ATP synthase activity and decrease Ψ m (Fleury et al., 1997; Echtay et al., 2001 ). The transcription, translation, and activity of endogenous uncoupling proteins are each regulated by multiple factors (Donadelli et al., 2014; Lapp et al., 2014) .
There are 5 members of the uncoupling protein gene family (Bouillaud et al., 2001) . The mitochondrial uncoupling protein 2 gene (Ucp2) is expressed in a variety of tissues, including the central nervous system (Pecqueur et al., 2001; Richard et al., 2001) , and codes for a 309 amino acid protein (Fleury et al., 1997) . UCP2 activity decreases electron transport chain efficiency, increasing energy expenditure (Zhang et al., 2001 ) and decreasing ROS generation (Nègre-Salvayre et al., 1997; Arsenijevic et al., 2000) . UCP2-mediated uncoupling of mitochondria is cytoprotective under a variety of stressful conditions (Mattiasson et al., 2003; Andrews et al., 2005; Barnstable et al., 2016) . As a consequence of Ucp2 deletion, mice have more ROS and are more susceptible to cell death following acute exposure to stressors such as the dopamine cell toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (Andrews et al., 2005) or focal ischemia (Haines et al., 2010) . Notably, Ucp2 deletion can be protective (de Bilbao et al., 2004) , deleterious (Andrews et al., 2005; Haines et al., 2010) , or have no clear effect on cell survival (Barnstable et al., 2016) in different models of neurodegeneration.
The goal of this study was to determine whether UCP2 normally functions to limit oxidative stress during glaucoma, thereby preventing a more severe form of the disorder. Glaucoma is a disease in which there are greater levels of ROS, and Ucp2 deletion increases the generation of ROS (Arsenijevic et al., 2000) . We therefore hypothesized that decreasing UCP2 levels would increase ROS and RGC death. However, our data suggest that by regulating mitochondrial dynamics, decreases in UCP2 levels can decrease the accumulation of oxidative damage to the retina and prevent retinal ganglion cell death.
Materials and Methods

Ethical approval
This study was carried out in accordance with the National Research Council's Guide for the Care and Use of Laboratory Animals (8th edition). The protocol was approved by the Pennsylvania State University College of Medicine Institutional Animal Care and Use Committee.
Animals
Wild-type (WT, C57BL/6J) and transgenic mice were housed in a room with an ambient temperature of 25°C, 30-70% humidity, a 12-hr light-dark cycle, and ad libitum access to rodent chow. Transgenic mouse strains, B6;129S-Ucp2 tm2.1Lowl /J (Ucp2 fl/fl , Stock#: 022394), B6.Cg-Tg(GFAP-cre/ER T2 )505Fmv/J (Gfap-creER T2 , Stock#: 012849) (Ganat et al., 2006) , and Tg(Thy1-cre/ER T2 ,-EYFP)HGfng/PyngJ (Thy1-creER T2 , Stock#: 012708) (Young et al., 2008) were each generated on a C57BL/6J background and purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Ucp2 fl/fl mice contain LoxP sites flanking exons 3 and 4 of the Ucp2 gene. Gfap-creER T2 and Thy1-creER T2 mice express a fusion product of cre recombinase and an estrogen receptor regulatory subunit (creER T2 ) under the control of the hGFAP or Thy1 promoters. CreER T2 activity is regulated by the estrogen receptor modulator and tamoxifen metabolite 4-hydroxytamoxifen (Zhang et al., 1996) , and in our studies, cre-mediated recombination of exons 3 and 4 of Ucp2 was promoted in 1-2 month old mice by daily intra-peritoneal injections of 100 mg/kg tamoxifen (Sigma, T5648) dissolved in sunflower seed oil (Sigma, S5007) for 8 days. Ucp2 fl/fl mice were injected with tamoxifen at the same time points as experimental subjects.
Breeding Scheme
To produce mice in which Ucp2 is selectively deleted in , and the offspring of these pairings were used in this study.
IOP Measurement
Intra-ocular pressure (IOP) was measured in isoflurane-anesthetized mice using an Icare® TonoLab (Icare Finland Oy, Espoo, Finland) rebound tonometer, both before and after injection with polystyrene microbeads. Each reported measurement per mouse per eye is the average of 18 technical replicates. Though the amount of time under anesthesia has been shown to affect IOP (Ding et al., 2011) , mice were anesthetized for <10 minutes and yielded stable mean IOP measurements, particularly in control eyes. However, the work of Ding et al., 2011 leads us to believe that our method of measurement underestimates IOP values by at least 3 mmHg, and possibly more in bead-injected eyes (Ding et al., 2011) . Mice were only included in this study if their IOP was elevated by 3 mmHg, or if a t-test of their IOP over time between bead and PBS-injected eyes was statistically significant.
Genotyping
Tissue from ear punches was lysed and digested for genotyping. Ucp2 fl/fl mice were genotyped with PCR primers flanking a LoxP site on the Ucp2 gene (Table 1 , Ucp2 flox ). To determine whether CreER T2 -mediated Ucp2 exon3-4 excision had occurred within a subset of samples, the reverse primer was used together with a primer outside the LoxP-flanked region (Table 1 , Ucp2 Δ ). PCR conditions to amplify Ucp2
Flox or Ucp2 Δ were as follows: (1) 95°C-3 min, (2) 95°C-1 min, (3) 73°C-1 min, (4) 72°C-30 seconds, (5) Go to (2) for 15 cycles (-1°C/cycle), (6) 95°C-1 min, (7) 58°C-1 min, (8) 72°C-30 seconds, (9) Go to (6) for 20 cycles, (10) 95°C-10 min, (11) Hold at 4°C. Both the Thy1-CreER T2 and Gfap-CreER T2 genes were genotyped using primers binding to an internal region of Cre recombinase (Table 1, Cre). PCR conditions to amplify Cre were as follows: (1) 95°C-3 min, (2) 95°C-1 min, (3) 58.1°C-1 min, (4) 72°C-30 seconds, (5) Go to (2) for 29 cycles, 95°C-10 min, (6) Hold at 4°C (Ganat et al., 2006) .
Microbead Injection
We modeled glaucoma in mice by elevating IOP. (Sappington et al., 2010; Cone et al., 2012) . At least 24 hours prior to bead injection, we took a baseline IOP measurement to confirm that a given mouse had a 'normotensive' IOP. We found that prior to bead injection, IOP is very stable and can be well represented by a single pre-bead measurement (data not shown). We then anesthetized mice with an intraperitoneal (IP) injection of 100 mg/kg Ketamine and 10 mg/kg Xylazine, and treated each eye with topical proparacaine hydrochloride (0.5%) to further anesthetize and hydrate the cornea during injections. We then sterilized 1-and 6-µm diameter polystyrene microbeads (Polysciences, Cat#: 07310-15 and 07312-5) as noted in Cone et al., and estimated bead concentrations on a hemocytometer. We injected 2 µL of 6 µm (at 3x10 6 beads/µL) and 2 µL of 1 µm (at 1.5x10 7 beads/µL) microbeads through the cornea using a 50-100 µm cannula formed by a beveled glass micropipette connected by polyethylene tubing to a Hamilton syringe (Hamilton Company Reno, NV, USA). As an internal control, the same volume of sterile 1x phosphate buffered saline (PBS) was injected into the contralateral eye. We measured postoperative IOP every 3 days for 3 to measure changes in gene expression, mtDNA/nDNA, or mitochondrial function, or 30 days for all other forms of analysis. Following the terminal IOP measurement, mice were asphyxiated using a Euthanex SmartBox system, which automatically controls CO 2 dispersion, followed by cervical dislocation. Figure 1B illustrates a visual representation of this experimental design.
Cytochrome-C oxidase Histochemistry
Cytochrome-C oxidase (COX) activity was assayed using a modified procedure described by (Wong-Riley, 1979; Murphy et al., 2012) . Briefly, following euthanasia, unfixed mouse eyes were harvested, immediately frozen in OCT on dry ice, and cut in to 10 µm sections. Control and experimental samples were frozen and sectioned on the same slide to minimize potential slide-to-slide variability. Slides were incubated in an assay solution containing 4 mM 3',3'-diamidobenzadine, 100 µM cytochrome C (Sigma, Cat#: 2037), and 5 U/mL catalase (Sigma, Cat#: E3289) for 1h at 37°C. Assay control slides were additionally exposed to 5 mM NaN 3 , which inhibits COX activity.
Histology and Immunocytochemistry
Immunolabeling of sectioned retinal tissue was performed as previously described (Pinzon-Guzman et al., 2011) . Briefly, whole eyes were fixed in 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA, USA) in 1x PBS overnight at 4°C. The next day, eyes were divided in half with a scalpel blade. One half was frozen and sectioned, while the other was labeled as a whole-mount. Frozen tissue were embedded in a 2:1 mixture of 20% sucrose and OCT (Electron Microscopy Sciences), cooled to -20°C, and cut at a 10 µm thickness. Samples for each experiment were located on the same slide to control for assay variability. Prior to immunohistochemical labeling, we unmasked antigens in a pH 6.0 sodium citrate buffer. Sections were permeabilized with 0.2% Triton-X-100 in PBS, blocked with 5% nonfat milk, and incubated in primary antibodies (Table 2) overnight at 4 °C. The following day, sections were washed and incubated in secondary antibody for 3 hours, followed by incubation in 1 µg/mL Hochest-33258 for 20 minutes. After three washes, slides were mounted with 0.5% n-propyl gallate in 1:1 glycerol: PBS. Retinal whole mounts used a similar protocol but with the following modifications: antigens were not unmasked, tissue was incubated in primary antibody for 6 days at 4°C and secondary overnight at 4°C. Labeled tissue was imaged on an Fluoview FV1000 confocal microscope (Olympus). In each experiment, acquisition parameters for a given antibody were held constant. RGCs were counted using the marker RBPMS (Rodriguez et al., 2014) in tissue whole-mounts 1000 µM from the optic nerve head, and the counter was blinded to the identity of each sample. All fluorescent labeling intensity measurements were derived using the ImageJ measurement tool. We measured colocalization between LC3B and TOMM20 using the ImageJ plugin "Coloc 2" and reporting the Manders' overlap coefficient corresponding to the TOMM20 image channel. Unless otherwise specified, intensity measurements were bounded by the ganglion cell layer and the outer nuclear layer.
RNA Isolation and Quantitative Real-Time PCR
Frozen tissue was lysed in TRIzol (Thermo-Fischer, Cat#:15596018) and RNA precipitated using the manufacturer's recommended procedure. Final RNA concentration was measured using a NanoDrop ND-1000 Spectrophotometer prior to reverse transcription. We reverse transcribed RNA using SuperScript III (ThermoFischer, Cat#: 18080093) with random hexamers. Genomic and mitochondrial DNA amplified via qPCR was isolated using a DNeasy Blood and Tissue kit (Qiagen, Cat#: 69504) in accordance with the manufactures' specifications. DNA was amplified with iQ SYBR Green Supermix (Bio-Rad, Cat#: 1708882) and quantitated on a Bio-Rad iCycler. All primers designed to measure gene expression (Table 1) do not amplify genomic sequences, and qPCR reactions were followed by a melt curve analysis to confirm the amplification of a single PCR product. All results were normalized against the TATA-box binding protein (Tbp) cDNA using the ΔΔC t method. Tbp is stably expressed during both mouse retinal development (Adachi et al., 2015) and in retinal endothelial cells treated with innate immune system stimulants (Wei et al., 2013) .
Primary Astrocyte Culture
Primary mouse cortical astrocytes were isolated from postnatal day 1-4 mice as previously described (Sarafian et al., 2010; Lapp et al., 2014) . Briefly, mice were decapitated and brains were removed from the skull. In tissue culture medium, a ~1 cm portion of superior cerebral cortex was pinched off of the brain using curved forceps. Meninges were removed, and the tissue was triturated with a sterile flame-polished glass Pasteur pipette until it formed a single cell suspension, approximately 20x. The suspension was filtered through a 70 µm cell strainer to remove larger debris, centrifuged at 500 x g and 4°C for 5 min, resuspended in growth medium (Dulbecco's Modified Eagle's Medium/Ham's F12 supplemented with 2 mM L-glutamine, 15 mM HEPES, 10% fetal bovine serum, and 10 ng/mL gentamicin), and plated in a T-25 tissue culture flask. Cells were grown at 37°C in a 5% CO 2 /balance air atmosphere. After the cells have reached confluence between 7-14 days in vitro (DIV), contaminating cells were shaken off at 250 RPM overnight and growth medium was replaced. Astrocyteenriched cultures were then passaged at least 48 hours following medium replacement for experimentation, and used for experimentation at passage #2 or 3. All cells used in this study were exposed to 1 µM 4-hydroxytamoxifen (Sigma, Cat#: H6278) for 24 hours prior to studies of Ucp2 function.
Measurement of Mitochondrial Membrane Potential and Oxidative Status
We determined mitochondrial membrane potential (Ψ m ) and relative oxidative status were determined on a fluorescence-enabled microplate reader (BioTek Synergy II) using black tissue-culture-treated 96-well plates (Corning, Cat#3603) seeded with 30,000 cells/well. We treated all primary astrocytes from Ucp2 fl/fl and Ucp2 fl/fl ; GfapcreER T2 mice with 4-hydroxytamoxifen and washed it out at least 24 hours prior to the assay. To measure membrane potential, we loaded cells with 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethyl-benzimidazolylcarbocyanine iodide (JC-1; 2 µg/mL; Thermo-Fischer, Cat#: T3168) in culture medium for 30 min. We measured red and green fluorescence 5 minutes after washing out each probe. Each assay contained controls treated with the membrane permeant protonophore Carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP, 1 µM, Caymen Chemical). We determined the effect of UCP2 on oxidant production using the redox-sensitive probe Chloromethyl-2′,7′-dichlorofluorescein diacetate (CM-H 2 -DCFDA, 40 µM; Thermo-Fischer, Cat#: C6827) in 1x PBS supplemented with 1 mM glucose and 2 mM GlutaMax (Thermo-Fischer, Cat#: 35050-061). The probe was washed out following a 30-minute incubation. We measured oxidant production in the plate reader's kinetic mode, which took serial measurements of CM-H 2 -DCFDA fluorescence over time. The increase in fluorescence (ΔF) over 30 minutes was divided by initial fluorescent intensity (F 0 ). This rate of increase in CM-H 2 -DCFDA fluorescence was normalized to the mean ΔF/F 0 of Ucp2 fl/fl cells to minimize inter-assay variability.
Extracellular Flux Analysis
Oxygen consumption (OCR) and extracellular acidification rate (ECAR) were used as proxies of oxidative and glycolytic metabolism, respectively. We performed a 'mitochondrial stress test' on cultured astrocytes (seeded at 30,000 cells/well) using inhibitors of electron transport at the indicated final concentrations: oligomycin (25 µg/mL; Caymen Chemical), FCCP (1 µM), antimycin A (1 µM), and rotenone (1 µM). Following the assay, we measured DNA concentration in each well for normalization of OCR traces.
Statistical analysis
We performed all statistical analyses in GraphPad Prism. We determined the statistical effect of one independent variable on 2 groups used a Student's t-test or paired sample t-test in cases where samples were matched (e.g. the control was the contralateral eye of the same animal). We analyzed the effect of one variable on >2 groups using a one-way ANOVA with a Bonferroni's post-hoc analysis. We analyzed the effect of 2 variables using a 2-way ANOVA with a Bonferroni's post-hoc analysis. The statistical significance threshold was p<0.05 for all tests.
Results
UCP2 Localization in the Retina and Characteristics of the Microbead Model
To confirm that UCP2 is normally present in the retina and to determine its cellular localization, we immunolabeled fixed retinal tissue from wild-type C57BL6/J and whole-body Ucp2 knockout mice (courtesy of Dr. Tamas Horvath). Retinas from Ucp2-knockout mice were used as a control for antibody specificity. UCP2 was distributed throughout the mouse retina, with strong expression within the retinal ganglion cell layer (GCL) and photoreceptor inner segments (upper panel, Fig. 1A ). In order to study the actions of UCP2 in a mouse model of glaucoma, we implemented a microbead model that elevates intra-ocular pressure (IOP), illustrated in Figure 1B . Prior to further studies, we confirmed that neither gender nor genotype had an effect on the baseline IOP characteristics of the mouse eye (Fig. 1C) . We also confirmed that injection of microbeads in to the anterior chamber of the eye resulted in their migration to the aqueous humor outflow pathway, at the irido-corneal angle (Fig. 1D) . Finally, we found a relationship between the bead-induced increase in IOP and a decrease in RGC survival, measured by a decrease in the density of RBPMS+ retinal ganglion cells in retinal whole-mounts (Fig. 1E) .
Elevated IOP decreases mitochondrial function and increases oxidative stress
One stable mark of oxidative damage is accumulation of lipid peroxidation products such as 4-hydroxy-2-nonenal (HNE). HNE can modify histidine residues on proteins, forming a stable adduct that we used as a proxy for oxidative stress in tissue. To determine whether the retina is oxidatively stressed in the microbead glaucoma model, we compared HNE labeling in the retinal layers of microbead-and PBS-injected eyes. Microbead-injection significantly increased HNE reactivity in the inner retina to 159±29% of contralateral PBS-injected eyes (p=0.0035, df=36, n=5), but not in the outer retina (98±23% of contralateral control). Analysis of individual inner retinal layers showed increases in HNE but none of these reach significance following adjustment for multiple comparisons, suggesting that the effects of IOP on oxidative stress occur in multiple cell types (Fig 2A-B) . To determine the effect of IOP elevation on mitochondrial function, we tested cytochrome oxidase (COX) activity in fresh-frozen slices of retina from PBS-and Bead-injected mice and found that by 3 days post bead-injection, there was a significant decrease in retinal cytochrome oxidase activity (p=0.0313, df=4, n=5, Fig. 2C ). The decrease in COX activity preceded a decrease in mitochondrial copy number, determined by the mtDNA/nDNA ratio (Lee et al., 2014) . Relative to contralateral eyes, mtDNA/nDNA was not altered 3 days following bead injection (t-test, ns, n=3), but was significantly decreased (52±8%) by 30 days (p=0.041, df=9, n=8, Fig.  1D ). We also determined the expression of the oxidative stress and glaucoma related genes Hmox1, Nfe2l2, C1Qa, Ucp2, Sod2, and C1Qa in untreated (naïve) retinas, PBSinjected, and microbead-injected retinas, 3 days post bead injection (n=3, df=6). Beadinjection increased the expression of Hmox1 (856±294%, p=0.019), Nfe2l2 (149±14%, p=0.029), and C1Qa (728±295%, p=0.043) relative to contralateral bead-injected retinas, and caused smaller, non-significant increases in Sod2 (117±35%, ns) and notably in Ucp2 as well (366±196%, ns, Fig. 2E ). In all cases, the expression of these genes was unchanged between naïve and PBS-injected retinas. In all subsequent experiments we used contralateral PBS-injected retinas as a control for microbeadinduced IOP elevation.
Ucp2 Deletion Increases Mitochondrial Membrane Potential (Ψ m ) and Oxidative Stress
To investigate the effects of Ucp2 deletion on cellular function, we used primary cortical astrocytes cells from Ucp2 fl/fl and Ucp2 fl/fl ; Gfap-creER T2 mice. In figure 3A (II) we show a schematic diagram of the floxed Ucp2, including the region excised by cre recombinase, and the PCR primers used to diagnose genotype or cre recombination. We also show the two different variants of cre used in this study (I) as well as (III) a schematic indicating which figures use primary cells and which used retinal tissue. In figure 3B we show an example gel from 4-hydroxytamoxifen-pretreated Ucp2 fl/fl (Fig. 3B,  lanes 1-2) and Ucp2 fl/fl ; Gfap-creER T2 astrocytes (lanes 3-4), from which we amplified a PCR product (Ucp2 Δ ) that is only detected in cre-expressing cells, following cremediated Ucp2 exon3-4 excision. We determined the effect of Ucp2 on mitochondrial transmembrane potential (Ψ m ), oxidative stress, and cell respiration using these astrocytes. We measured Ψ m using the vital dye JC-1, which equilibrates in mitochondria as red fluorescent aggregates and outside as green fluorescent monomers. The ratio of aggregate/monomers is proportional to Ψ m , and we found that Ucp2 deletion increased Ψ m to 120±7% of control samples (p=0.026, df=15, n=7-8). As a control, we applied the membrane-permeant protonophore FCCP (1 µM), which reduced Ψ m to 72±4% of controls (p=0.013, df=15, Fig. 3C ). Oxidative stress was measured using CM-H 2 -DCFDA, a cell permeant probe that becomes fluorescent upon oxidation, and we measured the rate (ΔF/F 0 ) of probe oxidation over 30 minutes. Relative to Ucp2 fl/fl controls, Ucp2 deletion increased oxidative stress to 133±12% (p=0.0452, df=16, n=7). As a control to verify assay function, Ucp2 fl/fl cells were treated with 4 µM Antimycin A, which also increased oxidative stress to 122±10% of controls (ns, df=16, n=5, Fig 3D) (Fig. 3E) .
Ucp2 deletion prevents retinal ganglion cell loss during glaucoma
Cre-mediated Ucp2 deletion was confirmed by measuring transcript levels, which were decreased in the retinas of tamoxifen-pretreated Ucp2 fl/fl ; Gfap-creER T2 and Ucp2 fl/fl ; Thy1-creER T2 mice to 62±16% and 68±17% of Ucp2 fl/fl , respectively (Fig. 4A ). Mice with Ucp2 selectively deleted in Gfap or Thy1-expressing cells were subjected to intraocular bead injection. Using reporter mice in which EGFP or YFP are co-expressed with cre recombinase, we confirmed the localization of these cre variants to retinal glia or ganglion cells (Fig. 4B) (Fig. 4D) . We determined the effect of glaucoma on RGC density using a 2-way ANOVA with Genotype and Bead-Injection as independent variables. A Bonferroni post-hoc analysis revealed that bead-injection significantly decreased retinal RGC density by 607±148 cells/mm 2 Fig. 4D -E). These data suggest that surprisingly, lack of UCP2 in the retina decreases the damage to RGCs caused by IOP elevation.
The Mechanism of Ucp2-deletion mediated neuroprotection
To determine the effect of UCP2 on retinal oxidative stress, we measured HNE immunoreactivity in the retinas of bead-injected eyes from Ucp2 fl/fl , Ucp2 fl/fl ; GfapcreER T2 and Ucp2 fl/fl ; Thy1-creER T2 mice (Fig. 5A-B (Fig. 5D ). We hypothesized that because mitochondria are less dense in retinal glia than in ganglion cells, a change in glial mtDNA/nDNA may occur and not be detectable in the retina. To test whether Ucp2 deletion alters mitochondrial copy number in glia, we used primary cultures of cortical astrocytes, and found that Ucp2 deletion did increase mtDNA/nDNA levels (p= 0.023, df=4, n= 3, Fig. 6A ).
We next determined the expression of three genes involved in mitochondrial biogenesis, PolgA, Tfam, and PGC1-α. These genes were not significantly altered by Ucp2 deletion in primary Ucp2 fl/fl ; Gfap-creER T2 astrocytes, though the expression of nuclear and mitochondrial genes associated with mitochondrial function (CytB, Sod2) were significantly decreased (p=0.037 and 0.024 respectively, df=27, n=3-4, Fig. 6B ). Since the UCP2-dependent alteration in mtDNA/nDNA did not appear to be due to a change in mitochondrial biogenesis, it may have resulted from an increase in degradation through mitochondrial autophagy ("mitophagy"). To test this, we measured the subcellular distributions of the autophagosome protein LC3B and the mitochondrial marker Tomm20 in primary cultures of cortical astrocytes (Fig. 6C-D) . Using the Coloc2 plugin on ImageJ, we determined the Manders' overlap coefficient corresponding to the proportion of co-localized (LC3B+ Tomm20+) pixels over Tomm20+ pixels (tM2). Ucp2 deletion significantly increased tM2 from 0.044±0.019 to 0.128±0.024 (p=0.033, df=6, n=3-4, Fig. 6D ). tM2 also increased to a greater extent in Ucp2 fl/fl astrocytes treated with 10 µM FCCP for 3h, a treatment known to reproducibly induce mitochondrial fragmentation and mitophagy (0.246±0.074). Mitochondria destined for destruction become porous, so if mtDNA escapes from these damaged mitochondria to the cytosol and avoided destruction, it would explain elevated mtDNA/nDNA levels in (Fig. 6E ). We performed similar forms of analysis on retinal tissue to determine whether Ucp2 impacts mitochondrial biogenesis or markers of mitophagy. Similar to our findings in astrocytes, we found no difference in the expression of PolgA, Tfam, and PGC1-α (Fig. 7A) (Fig. 5E-F) , suggesting that Ucp2 deletion results in greater levels of autophagy within both cell types of the retina (Fig.  7B-C) .
Discussion
Mitochondrial dysfunction and oxidative stress are central to the pathophysiology of glaucoma and have been observed in both animal models and human tissue (Moreno et al., 2004; Malone and Hernandez, 2007; Lee et al., 2011; Mousa et al., 2015; Khawaja et al., 2016) . Following a microbead injection, we confirmed the role of elevated IOP in RGC death (Fig. 1) , mitochondrial dysfunction, and oxidative stress (Fig. 2) .
Previous studies have shown that greater levels of Ucp2 expression is protective against various conditions that increase oxidative stress, including excitotoxicity and MPTP-induced parkinsonism (Diano et al., 2003; Andrews et al., 2005; Barnstable et al., 2016) . We have found that UCP2 is highly expressed in the inner retina (Fig. 1A) , an area greatly affected by oxidative stress in glaucoma, and have verified its role in the regulation of Ψ m and oxidative stress in a cellular system (Fig. 3C-D) . Muller glia, astrocytes, and RGCs all exist within the inner retina and each regulate the bioenergetic and oxidative status of ganglion cells (Kawasaki et al., 2000) .
To determine whether UCP2 alters the progression of glaucoma, and the cell types within which its actions are most important, we used mice in which Ucp2 was selectively deleted in Gfap-expressing (astrocytes and müller glia) or in Thy1-expressing cells (retinal ganglion cells; Fig. 4) . We increased the IOP of these mice by injecting microbeads and found that while an elevated IOP may increase RGC loss ( Fig.  4C-E ), reactive gliosis ( Fig. 5C ) and retinal damage (Fig. 5A-B (Fig 5D) . We believe that analysis of retinal mtDNA/nDNA is more sensitive to RGCs as they have a high density of mitochondria, and when we investigated the mtDNA/nDNA in primary astrocytes, we also found a significant increase following Ucp2 deletion (Fig. 6A) . These findings led us to investigate the role that Ucp2 might play in regulating mitochondrial dynamics.
We first investigated mitochondrial biogenesis, which did not appear to be correlated with mtDNA/nDNA, as Tfam, Pgc1-α, and PolgA were unchanged by Ucp2 deletion in culture or in Ucp2 fl/fl ; Thy1-creER T2 and Ucp2 fl/fl ; Gfap-creER T2 retinas ( Fig.  6B and 7A) . However, the expression of the mitochondrial genes CytB and Sod2 was significantly decreased in Ucp2 fl/fl ; Gfap-creER T2 astrocytes, leading us to investigate the effect of Ucp2 deletion on the degradation of mitochondria, dubbed mitophagy. Mitophagy is a form a quality control in which damaged mitochondria are selectively degraded (Kim et al., 2007) . We found greater levels of mitophagy in Ucp2 deleted astrocytes (Fig. 6C-D) , and confirmed that the marker of autophagy, LC3B, was significantly increased in the retinas of Ucp2 fl/fl ; Gfap-creER T2 and Thy1-creER T2 mice (Fig. 7B-C) . The increase in LC3B was greatest in Ucp2 fl/fl ; Gfap-creER T2 retinas, suggesting that loss of Ucp2 in astrocyte and müller glia strongly activates mitophagy. Retinal glia are phagocytic cells (Bejarano-Escobar et al., 2017) , and astrocytes of the optic nerve head are specifically able to phagocytose and dispose of damaged RGC mitochondria (Davis et al., 2014) . If a Ucp2-deletion dependent increase in glial mitophagy increases the disposal of RGC mitochondria, it would explain why Ucp2 fl/fl ; Gfap-creER T2 mice are protected from glaucoma. Ucp2 fl/fl ; Thy1-creER T2 mice are most likely protected from glaucoma because Ucp2 deletion within RGCs is expected to directly increase mitophagy.
Our data suggest that Ucp2 deletion increases mitochondrial quality control, clearing damaged mitochondria and improving bulk mitochondrial function. These data are supported by a previous study, which found that Ucp2 deletion increases mitophagy in pulmonary endothelial cells (Haslip et al., 2015) . An effect of UCP2 on mitophagy would also explain how Ucp2 deletion increases basal and maximal (FCCP-induced) astrocyte respiration without altering oligomycin-insensitive respiration (Fig. 3E) , as having a greater proportion of functional mitochondria can increase a cell's capacity for respiration (Drew et al., 2014) . While these data are contrary to the canonical function of an uncoupling protein, the process of mitophagy specifically selects dysfunctional mitochondria for degradation (Lemasters, 2005; Kim and Lemasters, 2011) and this activity could result in cells enriched for undamaged mitochondria. Greater levels of mitophagy can protect the retina from glaucoma, as a study recently demonstrated by manipulating levels of the E3 ubiquitin ligase Parkin. Overexpression of parkin in the rat retina stimulated retinal mitophagy, which was also protective against glaucomatous retinal ganglion cell death (Dai et al., 2018) . Our data show UCP2 to be a regulator of mitochondrial homeostasis, as increased expression prevents damage from oxidative stress, and reduced expression can initiate mitophagy to mitigate exogenous increases in oxidative stress.
Conclusions
Overall, we have arrived at a model of how Ucp2 deletion may protect tissues from mitochondrial damage. Ucp2 deletion increases membrane potential and consequently increases the generation of free radicals. Sub-lethal levels of free radicals are a signal for mitophagy (Frank et al., 2012) , and so mitochondria that generate greater levels of free radicals select themselves for degradation through mitophagy. In bulk, this likely increases mitochondrial turnover and improves respiratory function for a tissue, leading to a reduction in free radicals that are generated by damaged mitochondria during glaucoma or possibly other pathogenic conditions.
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